Acadia Healthcare Company, Inc. (ACHC) stock
ACHCNasdaqServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/3046% below fair value
$37.94−0.76 (-1.96%)
Close on Nov 17, 2026Market cap $3.53BP/E –Yield –
Acadia Healthcare revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Acadia Healthcare's revenue for the twelve months ending Jun 30, 2026 was $3.37B, up 4.3% year over year. For fiscal 2025 it was $3.31B, up 5.0% from the year before. The highest annual figure on record is $3.31B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.31B | +5.0% |
| FY2024 | Dec 31, 2024 | $3.15B | +7.7% |
| FY2023 | Dec 31, 2023 | $2.93B | +12.2% |
| FY2022 | Dec 31, 2022 | $2.61B | +12.8% |
| FY2021 | Dec 31, 2021 | $2.31B | +10.7% |
| FY2020 | Dec 31, 2020 | $2.09B | +4.1% |
| FY2019 | Dec 31, 2019 | $2.01B | +5.4% |
| FY2018 | Dec 31, 2018 | $1.90B | -32.8% |
| FY2017 | Dec 31, 2017 | $2.84B | +0.9% |
| FY2016 | Dec 31, 2016 | $2.81B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $865.84M | -0.4% |
| Q1 FY2026 | Mar 31, 2026 | $828.80M | +7.6% |
| Q4 FY2025 | Dec 31, 2025 | $821.46M | +6.1% |
| Q3 FY2025 | Sep 30, 2025 | $851.57M | +4.4% |
| Q2 FY2025 | Jun 30, 2025 | $869.23M | +9.2% |
| Q1 FY2025 | Mar 31, 2025 | $770.51M | +0.3% |
| Q4 FY2024 | Dec 31, 2024 | $774.24M | +4.2% |
| Q3 FY2024 | Sep 30, 2024 | $815.63M | +8.7% |
| Q2 FY2024 | Jun 30, 2024 | $796.04M | +8.8% |
| Q1 FY2024 | Mar 31, 2024 | $768.05M | +9.1% |
| Q4 FY2023 | Dec 31, 2023 | $742.80M | +10.0% |
| Q3 FY2023 | Sep 30, 2023 | $750.33M | +12.5% |
| Q2 FY2023 | Jun 30, 2023 | $731.34M | +12.2% |
| Q1 FY2023 | Mar 31, 2023 | $704.27M | +14.2% |
| Q4 FY2022 | Dec 31, 2022 | $675.30M | +13.8% |
| Q3 FY2022 | Sep 30, 2022 | $666.73M | +13.5% |
| Q2 FY2022 | Jun 30, 2022 | $651.72M | +11.9% |
| Q1 FY2022 | Mar 31, 2022 | $616.65M | +11.9% |
| Q4 FY2021 | Dec 31, 2021 | $593.48M | +9.6% |
| Q3 FY2021 | Sep 30, 2021 | $587.56M | +7.2% |
| Q2 FY2021 | Jun 30, 2021 | $582.16M | +18.5% |
| Q1 FY2021 | Mar 31, 2021 | $551.20M | +8.2% |
| Q4 FY2020 | Dec 31, 2020 | $541.28M | +8.0% |
| Q3 FY2020 | Sep 30, 2020 | $547.96M | +7.6% |
| Q2 FY2020 | Jun 30, 2020 | $491.48M | -3.6% |
| Q1 FY2020 | Mar 31, 2020 | $509.22M | +4.4% |
| Q4 FY2019 | Dec 31, 2019 | $501.23M | -32.6% |
| Q3 FY2019 | Sep 30, 2019 | $509.38M | -33.1% |
| Q2 FY2019 | Jun 30, 2019 | $509.81M | -33.4% |
| Q1 FY2019 | Mar 31, 2019 | $487.96M | -34.3% |
| Q4 FY2018 | Dec 31, 2018 | $743.55M | +2.6% |
| Q3 FY2018 | Sep 30, 2018 | $760.92M | +6.2% |
| Q2 FY2018 | Jun 30, 2018 | $765.74M | +7.0% |
| Q1 FY2018 | Mar 31, 2018 | $742.24M | +9.3% |
| Q4 FY2017 | Dec 31, 2017 | $724.51M | – |
| Q3 FY2017 | Sep 30, 2017 | $716.71M | – |
| Q2 FY2017 | Jun 30, 2017 | $715.90M | – |
| Q1 FY2017 | Mar 31, 2017 | $679.19M | – |
See a number that looks wrong?